Evidence map›Paper›PMID 40467047›Full record

ArticleBiopolymers2025

Gallic Acid Loaded Alginate-Gelatin Beads for Potential Bone Tissue Engineering Applications.

Mehmet Ali Karaca, Ali Reza Kamali, Bita Erin Kamali, Bilge Temiz, Furkan Özben, Duygu Ege, Hale Saybaşılı

Abstract read
In one paragraph

Article in Biopolymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mehmet Ali KaracaInstitute of Biomedical Engineering, Boğaziçi University, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-6328-3832
Ali Reza KamaliEnergy and Environmental Materials Research Centre (E2MC), School of Metallurgy, Northeastern University, Shenyang, China.
Bita Erin KamaliUCL Cancer Institute, University College London, London, UK.
Bilge TemizInstitute of Biomedical Engineering, Boğaziçi University, Istanbul, Turkey.
Furkan ÖzbenInstitute of Biomedical Engineering, Boğaziçi University, Istanbul, Turkey.
Duygu EgeInstitute of Biomedical Engineering, Boğaziçi University, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-9922-6995
Hale SaybaşılıInstitute of Biomedical Engineering, Boğaziçi University, Istanbul, Turkey.

Funding

Boğaziçi University Research Fund 20325Türkiye Bilimsel ve Teknolojik Araştırma Kurumu 123C322Türkiye Sağlık Enstitüleri Başkanlığı 44461
6 · The paper itself

Abstract

In this study, alginate/gelatin (AL/GEL) spherical beads are prepared and encapsulated with 1 wt % of needle-shaped gallic acid (GA) crystals to develop a drug delivery system. The % encapsulation efficiency of GA into AL/GEL beads, its release rate, and the stability of the beads are evaluated, followed by cytocompatibility studies. The interactions between GA, AL, and GEL are examined by using FTIR. Morphological observations reveal that increasing the GEL concentration above 0.4 wt.% possibly hinders the binding of calcium ions with the carboxylate groups of AL, resulting in the formation of beads with larger diameters. In contrast, the bead diameter decreases with the incorporation of GA due to hydrogen bonding. EDX analysis of GA-loaded AL/GEL beads indicated that GA binds to the GEL-rich region. Furthermore, EDX analysis of mineralized beads demonstrated that GA enhanced calcium deposition near the alginate-rich region. In vitro studies demonstrate that AL/GEL beads loaded with ≤ 0.5 (wt.) % GA are cytocompatible and MC3T3-E1 murine pre-osteoblast cells proliferated over a 5-day period. Overall, the prepared beads show potential as a drug delivery system for bone regeneration applications.

Indexed as

AlginatesBone and BonesGallic AcidGelatinMicrospheresTissue EngineeringAnimalsCell LineCell ProliferationDrug Delivery SystemsMiceOsteoblastsAlginatesGallic AcidGelatinalginate‐gelatin beadsbone tissue engineeringencapsulationgallic acidMC3T3‐E1

Identifiers

PMID40467047
PMCPMC12136859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.